tiprankstipranks
Trending News
More News >
Bionovate Technologies (BIIO)
OTHER OTC:BIIO
US Market

Bionovate Technologies (BIIO) Financial Statements

Compare
47 Followers

Bionovate Technologies Financial Overview

Bionovate Technologies's market cap is currently $8.00. The company's EPS TTM is $; its P/E ratio is ―; Bionovate Technologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -45.37K$ -33.05K$ -56.54K$ -118.88K
EBITDA$ -45.37K$ -33.05K$ -290.00$ 0.00
Net Income$ -106.54K$ -122.05K$ -208.90K$ -1.74M
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 0.00$ 0.00$ 0.00$ 0.00
Total Debt$ 237.38K$ 185.38K$ 183.67K$ 269.18K
Net Debt$ 237.38K$ 185.38K$ 183.67K$ 269.18K
Total Liabilities$ 503.21K$ 396.67K$ 332.29K$ 309.68K
Stockholders' Equity$ -503.21K$ -396.67K$ -332.29K$ -309.68K
Cash Flow
Free Cash Flow$ -236.00$ 102.00$ -292.00$ -1.50M
Operating Cash Flow$ -236.00$ 102.00$ -292.00$ -1.50M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 30.42K$ 0.00$ 11.40K
Currency in USD

Bionovate Technologies Earnings and Revenue History

Bionovate Technologies Debt to Assets

Bionovate Technologies Cash Flow

Bionovate Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.